You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage II childhood small noncleaved cell lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

Completed
Has Results
  • AIDS-related Diffuse Large Cell Lymphoma
  • +8 more
  • Eldoret, Kenya
  • +1 more
Sep 12, 2022

Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

Active, not recruiting
  • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
  • +22 more
  • External Beam Radiation Therapy
  • Orbital Radiation
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

Recruiting
  • Non-small Cell Lung Cancer
  • SH-1028 tablets
  • Placebo SH-1028 tablets
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Oct 6, 2023

Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

Not yet recruiting
  • Limited Stage Lung Small Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Nov 10, 2023

Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • hSTC810 400 mg + Paclitaxel
  • hSTC810 800 mg + Paclitaxel
  • (no location specified)
Aug 24, 2023

NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

Recruiting
  • NSCLC
  • SBRT+LDRT
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Apr 2, 2023

Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

Recruiting
  • Nonsmall Cell Lung Cancer
  • +3 more
  • Genomically Guided Radiation Therapy (RT)
  • Tampa, Florida
    Moffitt Cancer Center
May 23, 2023

Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

Not yet recruiting
  • NSCLC
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Aug 6, 2023

    Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)

    Recruiting
    • Extensive-stage Small Cell Lung Cancer
    • Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jul 27, 2023

    Unresectable Lung Non-Small Cell Carcinoma Trial (serplulimab plus chemo as conversion treatment)

    Not yet recruiting
    • Unresectable Lung Non-Small Cell Carcinoma
    • serplulimab plus chemotherapy as conversion treatment
    • (no location specified)
    Apr 27, 2023

    Relapsed or Refractory B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in Beijing

    Recruiting
    • Relapsed or Refractory B-cell Lymphoma
    • +6 more
    • Beijing, China
      Beijing Cancer Hospital
    Feb 6, 2023

    Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive, Hepatosplenic T-Cell Lymphoma Trial

    Completed
    Has Results
    • Anaplastic Large Cell Lymphoma, ALK-Negative
    • +9 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +8 more
    • Duarte, California
    • +7 more
    Nov 4, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Scottsdale, Arizona
    • +2 more
    Jan 5, 2023

    Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Jinan, China
    • +2 more
    Sep 10, 2023

    Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)

    Not yet recruiting
    • Extensive Stage Lung Small Cell Carcinoma
    • Stage IV Lung Cancer
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Oct 25, 2023

    NSCLC Trial (V940, Pembrolizumab, Placebo)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • V940
    • +2 more
    • (no location specified)
    Oct 5, 2023

    NSCLC Trial in Tianjin (Ensartinib, Placebo)

    Recruiting
    • Non-small Cell Lung Cancer
    • Tianjin, China
      TianJin Medical University Cancer Institute & Hospital
    Jul 13, 2022

    Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Non-Small Cell

    Active, not recruiting
    • Stage I Lung Non-Small Cell Cancer AJCC v7
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 24, 2022

    Lung Cancer, NSCLC Trial (Lorlatinib, Cisplatin or Carboplatin, Pemetrexed)

    Not yet recruiting
    • Lung Cancer
    • Non-small Cell Lung Cancer
    • (no location specified)
    Jul 7, 2023

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

    Terminated
    Has Results
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +12 more
    • Laboratory Biomarker Analysis
    • ROR1 CAR-specific Autologous T-Lymphocytes
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 11, 2022

    Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • Fungoides Mycosis Sezary Syndrome
    • Ann Arbor, Michigan
      University of Michigan Comprehensive Cancer Center
    Jul 13, 2023

    Extensive-stage Small-cell Lung Cancer Trial in Sydney, Brisbane, Melbourne (Radiotherapy, Chemotherapy)

    Recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Sydney, New South Wales, Australia
    • +6 more
    Mar 21, 2023

    Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)

    Recruiting
    • Extensive Stage Small Cell Lung Cancer
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Jun 6, 2023

    Small Cell Lung Cancer Trial in Changchun (BL-B01D1, SI-B003)

    Not yet recruiting
    • Small Cell Lung Cancer
    • Changchun, Jilin, China
      Jilin Cancer Hospital
    Jun 21, 2023

    Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,

    Active, not recruiting
    • Non-Squamous Non-Small Cell Lung Carcinoma
    • +7 more
    • Nivolumab
    • +3 more
    • Abington, Pennsylvania
    • +1 more
    Sep 14, 2022